by Eric Christianson | Jul 26, 2020 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Glucagon-like peptide-1 receptor agonists, or GLP-1s, are a highly appealing, newer class of medications for the treatment of type 2 diabetes. Through their activity at the GLP-1 receptor, they slow gastric emptying and decrease glucagon secretion. They also increase...
by Eric Christianson | Feb 19, 2020 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
A compelling indication is simply another reason (typically a disease state) as to why you choose a medication. Compelling indications in diabetes are increasingly important in medication selection in diabetes. I lay out some of those reasons below. Metformin...
by Eric Christianson | Sep 25, 2019 | Clinical Pharmacy News and New Drug Updates, Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
The author has no conflicts of interest regarding oral semaglutide or any other diabetes medication. The GLP-1 agonists have been growing in popularity. The benefit of good A1C lowering effect coupled with the potential for weight loss are two of the main reasons why...
